Health

Rinvoq (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)

DailyTrendDailyTrend
May 1, 2025 - 00:00
 0  1
Rinvoq (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved Rinvoq® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Daniel Radcliffe on Returning to Broadway in ‘Every Brilliant Thing’

Daniel Radcliffe on Returning to Broadway in ‘Every Bri...

DailyTrend Feb 17, 2026  0  1

Emergency Response Safety Kit Recall: Airlife Removes Certain Broselow Pediatric Emergency Rainbow Tapes and Broselow ALS Organizers

Emergency Response Safety Kit Recall: Airlife Removes C...

DailyTrend Feb 12, 2026  0  0

Senate Questions Health Care Firm for Profiting Off Program Meant for Poor

Senate Questions Health Care Firm for Profiting Off Pro...

DailyTrend Feb 12, 2026  0  1

Keytruda and Keytruda Qlex, Plus Paclitaxel ± Bevacizum...

DailyTrend Feb 12, 2026  0  1

Detachable Coil System Recall: J&J MedTech/CERENOVUS Inc. Remove CEREPAK Detachable Coil System

Detachable Coil System Recall: J&J MedTech/CERENOVUS In...

DailyTrend Feb 12, 2026  0  0

Electronic Homecare Bed Correction: Medline Updates Use Instructions for Homecare Beds

Electronic Homecare Bed Correction: Medline Updates Use...

DailyTrend Feb 17, 2026  0  1